WHO Names 17 Pathogens as Top Priorities for Global Vaccine Development

Amber Baker, AstraZeneca, CDC, Centers for Disease Control and Prevention, COVID-19, cytomegalovirus, E. coli, eBioMedicine, Future Vaccines, Group A streptococcus, Health Articles, Hepatitis C, HIV-1, Immunization, influenza vaccine, Kate O’Brien, Klebsiella pneumoniae, Leishmania, malaria, Mycobacterium tuberculosis, National Vaccine Information Center, Nebraska Medicine, non-typhoidal Salmonella, Norovirus, NVIC, Plasmodium falciparum, Respiratory Syncytial Virus, Robert Redfield, RSV, Shigella, taphylococcus aureus, TB bacteria, The Vaccine Reaction, United Kingdom, Vaccines and Biologicals Department, Vaxzevria, WHO, World Health Organization /

A new World Health Organization (WHO) study published in eBioMedicine last week highlights 17 viral and bacterial pathogens that are major sources of endemic disease around the world and that WHO officials believe should be urgently prioritized for vaccine development. The study marks the WHO’s first global effort to systematically prioritize endemic pathogens with epidemic […]

WHO Names 17 Pathogens as Top Priorities for Global Vaccine Development Read More »